This technology describes a bacteria-based multifunctional microrobot that moves via self-propulsion, achieved by self-assembling bacteria and target substances onto micro liquid crystal droplets containing phase defects.
Conventional microrobots had limited functionality due to complex manufacturing processes and limitations in precise actuation control.
This technology combines antibody-antigen reaction-based adhesive microparticles with self-propelling bacteria, enabling highly reliable functions such as drug detection and release even in unstructured environments.
US2024-0207438A1